Naoki Mori

From Wikipedia, the free encyclopedia
Jump to: navigation, search

Naoki Mori (森 直樹 Mori Naoki?) is a Japanese virologist who worked at the University of the Ryukyus in Okinawa Prefecture, Japan. He received numerous awards for his research on human T-cell leukemia virus type 1 (HTLV-1), a retrovirus which causes adult T-cell leukemia.[1][2]

Research fraud[edit]

In 2010, RetractionWatch reported that 5 of Mori's papers had been retracted by the journal Infection and Immunity. (The New York Times put the figure at six.[3])The papers, which were published between 2000 and 2009, described studies on H. pylori.[2][4] Mori was banned from publishing articles in journals operated by the American Society for Microbiology after it was determined that he had manipulated data and images in a number of articles.[2] As of October 2011, thirty papers coauthored by Mori have been retracted, including 5 from Infection and Immunity, 7 from the International Journal of Cancer,[5] 2 from Blood, 1 from Biochemical and Biophysical Research Communications titled Downregulation of citrin, a mitochondrial AGC, is associated with apoptosis of hepatocytes.[6][7] Mori took "full responsibility" for "multiple inaccurate and inappropriately duplicated" images,[8] and was dismissed from his university post in August 2010.[2]

After the dismissal in 2010, Naoki Mori was rehired and resumed publishing.[9] Recent publication included research paper titled 'Honokiol induces cell cycle arrest and apoptosis via inhibition of survival signals in adult T-cell leukemia'.[10]

References[edit]